About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Open Forum Infectious Diseases
›
Top Articles
Open Forum Infectious Diseases
Infectious Disease
,
Pathology
,
Oncology
1
(top 16%)
Impact Factor
1.1
(top 16%)
extended IF
78
(top 5%)
H-Index
3.9K
authors
15K
papers
465.4K
citations
3.3K
citing journals
29K
citing authors
Most Cited Articles of Open Forum Infectious Diseases
Title
Year
Citations
Weight gain after fecal microbiota transplantation
2015
272
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
2020
259
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
2015
239
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Species From 1997-2016
2019
227
Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs
2016
215
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
2020
190
Rates of pneumococcal disease in adults with chronic medical conditions
2014
145
A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis
2018
140
Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians
2015
129
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
2020
122
Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit
2018
120
C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation
2020
116
The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998-2011
2017
114
Phage Therapy for a Multidrug-Resistant Craniectomy Site Infection
2018
112
Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014
2015
107
Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus
2016
100
Vaccine Rejection and Hesitancy: A Review and Call to Action
2017
95
Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1
2015
91
Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to : Results of a Systematic Literature Review and Meta-analysis
2018
82
Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States
2020
82
Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
2019
79
Invasive Mold Infections (IMIs) of the Central Nervous System (CNS) in Patients with Hematologic Cancer (HC) (2000–2016): Uncommon but Deadly
2017
78
The Epidemiology of Non-tuberculous Mycobacteria (NTM) from Non-pulmonary Sites over 4 Years in Nebraska
2017
78
Pharmacodynamic Optimization for the Treatment of Invasive Candida auris Infection
2017
78
Primary or Secondary Prophylaxis with Voriconazole Compared with Posaconazole for Prevention of Invasive Fungal Infections After Hematopoietic Stem Cell Transplantation
2017
78
previous
2015
2016
2017
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.